Integrated Quantitative Investments’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-38,501
Closed -$323K – 430
2026
Q2
$323K Buy
+38,501
New +$322K 0.05% 321
2025
Q2
– Sell
-35,023
Closed -$170K – 395
2025
Q1
$170K Sell
35,023
-6,052
-15% -$50.1K 0.08% 270
2024
Q4
$393K Buy
+41,075
New +$377K 0.19% 150

Other funds holding EBS

Integrated Quantitative Investments's EBS Position: Q3 2026 in Review

Integrated Quantitative Investments sold out of Emergent Biosolutions (EBS) in Q3 2026, closing a stake of 38,501 shares — an estimated $323K sold.

Integrated Quantitative Investments first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $393K in Q4 2024. 186 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Integrated Quantitative Investments reported no remaining Emergent Biosolutions position as of Q3 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 38,501 Emergent Biosolutions shares in Q3 2026, an estimated $323K.
  • Integrated Quantitative Investments first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
  • Integrated Quantitative Investments's Emergent Biosolutions position peaked at $393K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.